Pediatric Hematology and Oncology

Pediatric Hematology and Oncology 由 Informa Healthcare 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Acute Lymphoblastic Leukemia research、Childhood Cancer Survivors' Quality of Life、Hemoglobinopathies and Related Disorders 等主题的论文，这 3 个主题约占 29.8%，主导子领域为 Hematology。（根据 OpenAlex 主题统计与中科院分区数据生成）

PHO: Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Our goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal supports articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences. Clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies and transplantation are of interest. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from scientists and clinicians across the international community of Pediatric Hematology and Oncology are considered for publication. The journal is not dependent on or connected with any organization or society. All submissions undergo rigorous peer review prior to publication. Our Editorial Board includes experts in Pediatric Hematology and Oncology representing a wide range of academic and geographic diversity.

来源：LetPub

研究方向（LetPub）：医学-小儿科

中科院期刊分区表

数据库收录

SCIEScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

1.26LetPub · 2026-09-13

CiteScore 2026-06

2.3LetPub · 2026-09-13

SJR 2026-06

0.39LetPub · 2026-09-13

SNIP 2026-06

0.52LetPub · 2026-09-13

h-index

38LetPub · 2026-09-13

h-index

62OpenAlex · 2026-10-01

i10-index

1,427OpenAlex · 2026-10-01

两年平均被引

1.14OpenAlex · 2026-10-01

自引率

7.1%LetPub · 2026-09-13

Gold OA 文章占比

3.48%LetPub · 2026-09-13

发文规模

年文章数

35LetPub · 2026-09-13

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

较慢,6-12周LetPub · 2026-09-13

平均录用比例（社区反馈）

容易LetPub · 2026-09-13

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

尚未从任何来源获得费用信息，请以期刊官网为准。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

出版商

Informa Healthcare

出版国家或地区

UNITED STATES

出版语言

English

出版周期

Bimonthly

创刊年份

1986

ISSN

0888-0018

电子版 ISSN

1521-0669

官方链接

• 期刊主页 ↗OpenAlex
• 投稿系统 ↗LetPub